Instruction for use: Hepalpan

Dosage form: Gel; ointment

Active substance: Heparinum natrium + [Allantoinum + Dexpanthenolum]

ATX

C05BA53 Heparin in combination with other drugs

Pharmacological groups

Anticoagulants in combination

Regenerants and reparants in combinations

The nosological classification (ICD-10)

I80 Phlebitis and thrombophlebitis: Diseases of peripheral vessels; Inflammation of superficial veins; Inflammatory diseases of veins; Deep venous thrombophlebitis; The disease of veins; Disease of the veins of the lower extremities; Diseases of peripheral vessels; Migrating phlebitis; Insufficiency of veins of lower extremities; Exacerbation of chronic thrombophlebitis; Acute thrombophlebitis; Acute thrombophlebitis of superficial veins; Periphlebitis; Periflebit surface; Superficial inflammation of veins; Surface thrombophlebitis; Surface phlebitis; Thrombophlebitis; Deep vein thrombophlebitis; Thrombophlebitis superficial; Phlebitis; Phlebitis of deep veins; Phlebitis of superficial veins; Phlebopathy; Chronic thrombophlebitis; Endophlebitis

I87.0 Postphlebitic syndrome: post-thrombotic venous insufficiency; Postthrombotic disease; Post thrombophlebitic syndrome; Post-thrombophlebitis; Post-thrombophlebitic syndrome; Postphlebitic syndrome; Post thrombotic syndrome; Postphlebitic syndrome (stasis syndrome)

T08-T14 Injuries to unspecified part of trunk, limb or body region

T14.3 Dislocation, sprain and damage to the capsular-ligamentous apparatus of the joint of the unspecified area of the body: Painful stretching of the muscles; Pain and inflammation in tension; Dislocation of dislocation; Degenerative changes in the ligamentous apparatus; Edema due to sprains and bruises; Edema after interventions during sprains; Damage and rupture of ligaments; The musculoskeletal system is damaged; Damage to ligaments; Damage to the joints; Ligament ruptures; Tendon tendons; Ruptures of the tendons of muscles; Stretching; Crick; Stretching of the muscle; Sprain; Tension of the tendons; Extensions; Stretch muscles; Sprains; Tension of the tendons; Injury of the musculoskeletal system; Injuries to the joints; Injuries of capsule-articular tissues; Injuries of the osteoarticular system; Injuries to ligaments; Injuries to the joints; Joint wounds; Stretching of the ligamentous apparatus; Stretching of the ligamentous apparatus; Habitual stretching and tearing

Composition and release form

100 g of gel (jelly) contain heparin sodium of 30,000 IU, allantoin and D-panthenol of 250 mg; In a tube 50 g.

100 g of ointment - heparin sodium 30,000 IU, allantoin 300 mg and D-panthenol 400 mg; In a tube 50 g.

Pharmachologic effect

Mode of action - Anticoagulant.

Prevents blood clotting and formation of blood clots, stimulates the development of granulations, epithelization and tissue regeneration, has a keratolytic effect.

Indications for the preparation Hepalpan

Phlebitis, superficial thrombophlebitis, pre-and post-phlebitis syndromes, traumas (bruises, bruises, sprains).

Contraindications

Bleeding trophic ulcers, decreased coagulability of blood.

Side effects

Allergic reactions.

Dosing and Administration

Topically, apply a thin layer on the affected area of the skin 2-3 times a day and lightly rub. Course - an average of 2 weeks.

Precautionary measures

Do not apply to mucous membranes and open wounds.

Storage conditions of the drug Hepalpan

Keep out of the reach of children.

The shelf life of the drug Hepalpan

Gel -

Ointment - 3 years.

Do not use beyond the expiration date printed on the package.